AREX – heavily shorted, earnings are coming (is anyone with a little Martha Stewart info leak around?), dilutive filings: FORT WORTH, Texas, Jan. 30, 2017 (GLOBE NEWSWIRE) — Approach Resources Inc. (AREX) (“Approach” or the “Company”) today announced the commencement of an offer (“Exchange Offer”) to exchange newly issued shares of its common stock, par […]
A few facts… Excerpts from the Company’s Financial Results for the Third Quarter Ended September 30, 2016: Total operating expenses for the quarter ended September 30, 2016 were $1,801,000, a decrease of 48.5% compared to $3,500,000 for the same period in 2015. This decrease was primarily due to a reduction of compensation related expenses, consultant […]
We are rarely re-posting articles but… no way to say better that Pros do: Silimed: Particles and Polymers – Professor J D Frame, Dr M Olivan The recent release of censured but commercially sensitive information on particle surface contamination of silicone implants via the Silimed information centre , the MHRA (Medicines and Healthcare Regulatory Agency), […]
Congratulations to everyone who’s followed our alert on SIEN Up to 15% in a matter of a few days – can you find a better trade from an entire Nasdaq? SIEN – we re-enter into at mid-day on Friday for a “hold” for a month or a few. Good reading: Sientra sends letter to surgeons […]
SIEN: see you at chart reversal News: SANTA BARBARA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will host an investor and analyst update conference call on Wednesday October 28, 2015 at 4:15 p.m. ET/1:15 p.m. PT. The dial-in numbers are (844) 464-3933 for […]
Is anyone wonder what would required from Sientra to re-open production in a new manufacturing facility? Sec. 814.39 PMA supplements. (a) After FDA’s approval of a PMA, an applicant shall submit a PMA supplement for review and approval by FDA before making a change affecting the safety or effectiveness of the device for which the […]
Sientra Inc. expected to be the queen of the breast-implant industry when it entered the U.S. market in 2012 with set of new shapes and textures – so much for women to choose from. Said so, the company was supplying about 9-10 percent of implants in the U.S., a.k.a. took roughly $30 million of $300 million […]
Rare Element Resources (REE) shares gained 20.86% on Friday’s trading session closed a few cents off of its monthly resistance within 4X 3month volume average: Classical chart setup, isn’t it? Rare Element Resources Ltd. is a mineral resource company focused on exploration and development of rare earth deposits, specifically those with significant distribution of critical […]
IFON announced on December 19, 2013 that it received a letter from the Nasdaq Listing Qualifications Staff (the “Staff”) advising that the Staff had determined that: The Company had not regained compliance with the $1.00 per share minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2) as of December 9, 2013 Unless InfoSonics requested an […]
GlassesOff (GLSO) could revolutionize how presbyopia is treated, all for 15 minutes a day, 3 days a week, for 2 – 3 months at most. Decades of research into neuroplasticity underlie a robust program that is developed as a ‘game’ that ‘trains’ your brain to better process near objects and images. GLSO recently announced the […]
